Brief: Aeterna Zentaris Says Qtrly Loss Per Share $0.05
March 30 (Reuters) - Aeterna Zentaris Inc AEZS.TO :
* AETERNA ZENTARIS REPORTS FOURTH QUARTER AND FULL-YEAR 2019
FINANCIAL AND OPERATING RESULTS AND PROVIDES BUSINESS UPDATE
* AETERNA ZENTARIS INC - CLOSELY MONITORING COVID-19 AND ITS
IMPACT ON BUSINESS AND OPERATIONS
* AETERNA ZENTARIS INC QTRLY LOSS PER SHARE $0.05
Source text for Eikon: ID:nGNXcc1vM3
Further company coverage: AEZS.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on COSCIENS Biopharma
See all newsBrief: COSCIENS Acquires Nualtis Corp
Refile: Canada's COSCIENS Biopharma Q2 net loss narrows on higher sales
Canada's COSCIENS Biopharma Q1 net income turns positive on discontinued German operations
Brief: Cosciens Biopharma Inc Not Aware Of Material Undisclosed Information Amid Recent Trading Activity
Brief: Cosciens Provides Strategic Update